Article
Metabolic rewiring in melanoma drug-resistant cells.
Critical reviews in oncology/hematology - 1 Sept 2020
Bristot Ivi Juliana, Kehl Dias Camila, Chapola Henrique, Parsons Richard B, Klamt Fábio
Abstract excerpt
Several evidences indicate that melanoma, one of the deadliest types of cancer, presents the ability to transiently shift its phenotype under treatment or microenvironmental pressure to an invasive and treatment-resistant phenotype, which is characterized by cells with slow division cycle (also called slow-cycling cells) and high-OXPHOS metabolism. Many cellular marks have been proposed to track this phenotype,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
